The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

被引：142
|
作者：
Gifford, Robert J. [1 ]
Liu, Tommy F. [1 ]
Rhee, Soo-Yon [1 ]
Kiuchi, Mark [1 ]
Hue, Stephane [2 ]
Pillay, Deenan [2 ,3 ]
Shafer, Robert W. [1 ]
机构：
[1] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
[2] UCL, Dept Infect, London WC1E 6BT, England
[3] Hlth Protect Agcy, Ctr Infect, Colindale, England
来源：
BIOINFORMATICS | 2009年 / 25卷 / 09期
关键词：
REVERSE-TRANSCRIPTASE; EPIDEMIOLOGIC SURVEILLANCE; ANTIRETROVIRAL TREATMENT; SEQUENCE; TRANSMISSION; MUTATIONS; PROTEASE; EUROPE;
D O I：
10.1093/bioinformatics/btp134
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
The calibrated population resistance (CPR) tool is a web-accessible program for performing standardized genotypic estimation of transmitted HIV-1 drug resistance. The program is linked to the Stanford HIV drug resistance database and can additionally perform viral genotyping and algorithmic estimation of resistance to specific antiretroviral drugs.
引用
收藏
页码：1197 / 1198
页数：2
相关论文
共 50 条
  • [1] Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance
    Liu, Lin
    May, Susanne
    Richman, Dous D.
    Hecht, Frederick M.
    Markowitz, Martin
    Daar, Eric S.
    Routy, Jean-Pierre
    Margolick, Joseph B.
    Collier, Ann C.
    Woelk, Christopher H.
    Little, Susan J.
    Smith, Davey M.
    [J]. AIDS, 2008, 22 (07) : 835 - 839
  • [2] Prevalence of HIV-1 transmitted drug resistance in the incarcerated population
    Sapozhnikov, J.
    Young, J. D.
    Patel, M.
    Chiampas, T. D.
    Vaughn, P.
    Badowski, M. E.
    [J]. HIV MEDICINE, 2017, 18 (10) : 756 - 763
  • [3] Prevalence of HIV-1 transmitted resistance in a surveillance study in central Mexico, according to calibrated population resistance
    Rodriguez-Diaz, R. A.
    Fuentes-Romero, L. L.
    Viveros-Rogel, M.
    Hernandez-Flores, M.
    Soto-Ramirez, L. E.
    [J]. ANTIVIRAL THERAPY, 2009, 14 (04) : A173 - A173
  • [4] Community HIV-1 drug resistance is associated with transmitted drug resistance
    Tilghman, M. W.
    Perez-Santiago, J.
    Osorio, G.
    Little, S. J.
    Richman, D. D.
    Mathews, W. C.
    Haubrich, R. H.
    Smith, D. M.
    [J]. HIV MEDICINE, 2014, 15 (06) : 339 - 346
  • [5] Interpretation systems for genotypic drug resistance of HIV-1
    De Luca, A
    Antinori, A
    Di Giambenedetto, S
    Cingolani, A
    Colafigli, M
    Perno, CF
    Cauda, R
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 : 29 - 34
  • [6] State of the art of genotypic HIV-1 drug resistance
    Schuurman, R
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 1997, 10 (06) : 480 - 484
  • [7] PRIMARY HIV-1 RESISTANCE - PERSISTENCE OF TRANSMITTED DRUG RESISTANCE MUTATIONS
    Nikolic, Valentina
    Salemovic, D.
    Jevtovic, D.
    Pesic-Pavlovic, I.
    Zerjav, S.
    Ranin, J.
    Siljic, M.
    Stanojevic, M.
    [J]. ARCHIVES OF BIOLOGICAL SCIENCES, 2012, 64 (04) : 1301 - 1309
  • [8] Persistence of HIV-1 Transmitted Drug Resistance Mutations
    Castro, Hannah
    Pillay, Deenan
    Cane, Patricia
    Asboe, David
    Cambiano, Valentina
    Phillips, Andrew
    Dunn, David T.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (09): : 1459 - 1463
  • [9] Prevalence of HIV-1 transmitted drug resistance in Liberia
    Loubet, P.
    Charpentier, C.
    Visseaux, B.
    Nuta, C.
    Adu, E.
    Chapplain, J. M.
    Baysah, M.
    Walters-Doe, S.
    Tattevin, P.
    Peytavin, G.
    Yazdanpanah, Y.
    Descamps, D.
    [J]. ANTIVIRAL THERAPY, 2014, 19 : A88 - A88
  • [10] Algorithms for the interpretation of HIV-1 genotypic drug resistance information
    Vercauteren, Jurgen
    Vandamme, Anne-Mieke
    [J]. ANTIVIRAL RESEARCH, 2006, 71 (2-3) : 335 - 342
12345